Holen Sie sich die Stockscreener-App
212.02
0.34%
0.71
Handel nachbörslich:
211.50
-0.52
-0.25%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$211.31
Offen:
$211.36
24-Stunden-Volumen:
1.28M
Relative Volume:
0.75
Marktkapitalisierung:
$49.89B
Einnahmen:
$244.67B
Nettoeinkommen (Verlust:
$1.68B
KGV:
30.51
EPS:
6.9487
Netto-Cashflow:
$5.51B
1W Leistung:
+0.34%
1M Leistung:
-7.51%
6M Leistung:
+34.25%
1J Leistung:
+54.61%
1-Tages-Spanne:
$210.08
$213.42
1-Wochen-Bereich:
$205.35
$213.42
52-Wochen-Spanne:
$120.72
$233.60
Cardinal Health Inc Stock (CAH) Company Profile
Firmenname
Cardinal Health Inc
Sektor
Branche
Telefon
(614) 757-3033
Adresse
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
212.02 | 49.72B | 244.67B | 1.68B | 5.51B | 6.9487 |
MCK
Mckesson Corporation
|
872.32 | 106.00B | 397.96B | 4.55B | 9.64B | 34.77 |
COR
Cencora Inc
|
317.66 | 61.11B | 325.78B | 1.64B | 3.61B | 8.3139 |
HSIC
Henry Schein Inc
|
73.04 | 8.45B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
2.32 | 1.95B | 14.85M | -136.07M | 7.23M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Hochstufung | Argus | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Underweight |
| 2023-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Eingeleitet | Citigroup | Neutral |
| 2023-02-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-05-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-05-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-20 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-27 | Herabstufung | Argus | Buy → Hold |
| 2019-08-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-16 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Hochstufung | Argus | Hold → Buy |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-01-05 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Cardinal Health Inc Aktie (CAH) Neueste Nachrichten
Cardinal Health, Shine Technologies amp up domestic production of radiopharmaceuticals - Healthcare Brew
Can CAH's Specialty Flywheel Strategy Unlock Long-Term Growth? - TradingView
Cardinal Health (CAH) Boosts Actinium-225 Production Capacity - GuruFocus
Cardinal Health (CAH) Boosts Actinium-225 Production for Future Therapies - GuruFocus
Nisa Investment Advisors LLC Trims Stock Position in Cardinal Health, Inc. $CAH - marketbeat.com
Cancer drug developers get more Actinium-225 as Cardinal Health expands - stocktitan.net
Can CAH’s Unique Specialty Flywheel Approach Drive Sustainable Growth Over Time? - Bitget
Cardinal Health, Inc. (NYSE:CAH) Short Interest Up 21.1% in March - marketbeat.com
Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo! Finance Canada
3 Dividend Stocks With High Returns on Invested Capital - Investing.com
Did Cardinal Health's (CAH) New Chair and Urology Deal Just Reframe Its Healthcare Partnership Strategy? - simplywall.st
Cardinal Health, Inc. $CAH Shares Sold by Wedge Capital Management L L P NC - marketbeat.com
-0.54% for Cardinal Health stock as price stays below key moving averages - Traders Union
Jim Cramer on Cardinal Health: "I want you to buy it and buy it, get this, aggressively" - MSN
Jim Cramer on Cardinal Health: “I Want You to Buy It and Buy It, Get This, Aggressively” - Insider Monkey
UBS reiterates Buy on Cardinal Health stock, $260 price target - Investing.com
Global X Japan Co. Ltd. Increases Position in Cardinal Health, Inc. $CAH - MarketBeat
Bethlehem - dailyvoice.com
Cardinal Health (CAH) Stock Moves -1.71%: What You Should Know - Yahoo Finance
Why The Narrative Around Cardinal Health (CAH) Is Shifting With New Targets And Guidance - Yahoo Finance
Cardinal Health Inc. stock outperforms competitors despite losses on the day - MarketWatch
Vanguard (CAH) parent reports zero CAH holdings after realignment - stocktitan.net
Cardinal Health (CAH) Appoints New Chair as Gregory Kenny Steps Down - insidermonkey.com
Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says - Infectious Disease Advisor
Cardinal Health Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Cardinal Health Inc. stock faces steady trading amid distribution sector pressures and healthcare su - ad-hoc-news.de
Cardinal Health appoints Patricia Hemingway Hall board chair - Drug Store News
Cardinal Health (CAH) Emerged as a Key Contributor on Pharmaceutical Strength and Margin Expansion - Yahoo Finance
Pensionfund Sabic Invests $1.79 Million in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Names New Chair As Valuation And Momentum Diverge - Sahm
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30 - Sahm
Avanza Fonder AB Lowers Stake in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Inc. stock shows steady trading on NYSE amid healthcare supply chain pressures and u - AD HOC NEWS
Cardinal Health, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Indicators - marketsmojo.com
Cardinal Health Stock Hits Day Low of $206.70 Amid Price Pressure - Markets Mojo
Assessing Cardinal Health (CAH) Valuation After Recent Share Price Weakness - sahmcapital.com
Cardinal Health Inc. stock faces steady trading amid healthcare supply chain shifts and sector headw - AD HOC NEWS
Cardinal Health vs. McKesson: Which Healthcare Giant Is the Smarter Bet? - The Globe and Mail
Cardinal Health (CAH) Surged Following Improved Specialty Mix in Pharma - Insider Monkey
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30 (2026-03-24) - Seeking Alpha
SG Americas Securities LLC Buys 708,995 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health names new board leader following chairman's sudden retirement - bizjournals.com
Cardinal Health Inc stock faces valuation scrutiny amid board changes and strong analyst support - AD HOC NEWS
WCM INVESTMENT MANAGEMENT, LLC's Cardinal Health Inc(CAH) Holding History - GuruFocus
Cardinal Health (CAH) Appoints New Board Chair - GuruFocus
Cardinal Health (NYSE:CAH) Strengthens Global Network For Russell 1000 Etf Watchers - Kalkine Media
Cardinal Health, Inc. Files Form 8-K with SEC Detailing Company Information and NYSE Listing - Minichart
Cardinal Health (CAH) Announces Board Leadership Changes and Upc - GuruFocus
Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH Stock? - TradingView
Cardinal Health Announces Board Changes, Effective March 23, 2026 - marketscreener.com
Cardinal Health Announces Board Chair Transition and Outlook - TipRanks
Finanzdaten der Cardinal Health Inc-Aktie (CAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):